Component

Human plasma hydroxy-fatty-acid oxidation biomarkers after astaxanthin

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. After 8 mg/day for three months, hydroxy-fatty-acid biomarkers decreased within the astaxanthin arm, but the reported between-group 15-HFA comparison was P=0.056.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human randomized supplementation study in men.
    limitations
    Preserve the comparator analysis; do not convert a borderline between-group result into proven benefit.
    nutrient_topic
    Astaxanthin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Astaxanthin
    plain_language
    A within-group improvement did not establish a statistically significant treatment difference.
    primary_references
    Effects of astaxanthin supplementation on lipid peroxidation. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17685090/ · DOI 10.1024/0300-9831.77.1.3

    Astaxanthin: transport, membrane chemistry, signaling and nutrient interactions (2026-09-19) · lines 422–428

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human randomized supplementation study in men. · source_derived_draft · unverified_draft

    ## astaxanthin-hydroxy-fatty-acid A within-group improvement did not establish a statistically significant treatment difference. After 8 mg/day for three months, hydroxy-fatty-acid biomarkers decreased within the astaxanthin arm, but the reported between-group 15-HFA comparison was P=0.056. Model: Human randomized supplementation study in men. Limitations: Preserve the comparator analysis; do not convert a borderline between-group result into proven benefit. Evidence access: Primary abstract Effects of astaxanthin supplementation on lipid peroxidation. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17685090/ · DOI 10.1024/0300-9831.77.1.3
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards